Acumen Pharmaceuticals, Inc. Contracts & Agreements
24 Contracts & Agreements
- Business Finance (5 contracts)
- Business Operations (4)
- Human Resources (12)
- Intellectual Property (1)
- Real Estate (2)
- Underwriting Agreement, dated July 18, 2023, among Acumen Pharmaceuticals, Inc. and BofA Securities, Inc., Citigroup Global Markets Inc. and Stifel, Nicolas & Company,... (Filed With SEC on July 20, 2023)
- Amendment No. 1 to the Sales Agreement, dated April 27, 2023, by and among Acumen Pharmaceuticals, Inc., BofA Securities, Inc., Stifel, Nicolaus & Company, Incorporated and BTIG,... (Filed With SEC on April 27, 2023)
- License Agreement, by and between the Registrant and Lonza Sales AG, dated November 2, 2022 (Filed With SEC on March 27, 2023)
- Lease Agreement, by and between the Registrant and Price-Poore House, LLC, dated September 28, 2022 (Filed With SEC on March 27, 2023)
- Lease Agreement, by and between the Registrant and Price-Poore House, LLC, dated December 1, 2022 (Filed With SEC on March 27, 2023)
- Description of the Companys Common Stock (Filed With SEC on March 28, 2022)
- Non-Employee Director Compensation Policy (Filed With SEC on March 28, 2022)
- Executive Employment Agreement, by and between the Registrant and Daniel OConnell (Filed With SEC on March 28, 2022)
- Executive Employment Agreement, by and between the Registrant and Matthew Zuga (Filed With SEC on March 28, 2022)
- Employment Agreement by and between the Registrant and Eric Siemers, M.D (Filed With SEC on March 28, 2022)
- Employment Agreement by and between the Registrant and Russell Barton (Filed With SEC on March 28, 2022)
- Employment Agreement by and between the Registrant and Matthew Zuga (Filed With SEC on August 16, 2021)
- Form of Underwriting Agreement (Filed With SEC on June 24, 2021)
- Collaboration Agreement, by and between the Registrant and Merck & Co., Inc., dated December 22, 2003, as amended and restated as of October 18, 2006 (Filed With SEC on June 24, 2021)
- 2021 Equity Incentive Plan and Forms of Option Grant Notice and Agreement, Exercise Notice, Early Exercise Notice and Restricted Stock Award Notice (Filed With SEC on June 24, 2021)
- Non-Employee Director Compensation Policy (Filed With SEC on June 24, 2021)
- 2021 Employee Stock Purchase Plan (Filed With SEC on June 24, 2021)
- Form of Indemnification Agreement with Executive Officers and Directors (Filed With SEC on June 24, 2021)
- Amended and Restated Investors Rights Agreement, by and among the Registrant and certain of its stockholders, dated November 20, 2020 (Filed With SEC on June 9, 2021)
- Collaboration Agreement, by and between the Registrant and Merck & Co., Inc., dated December 22, 2003, as amended and restated as of October 18, 2006 (Filed With SEC on June 9, 2021)
- 2013 Amended and Restated Stock Performance Plan (as amended through November 20, 2020) (Filed With SEC on June 9, 2021)
- Executive Employment Agreement, by and between the Registrant and Daniel OConnell (Filed With SEC on June 9, 2021)
- Employment Agreement by and between the Registrant and Eric Siemers, M.D (Filed With SEC on June 9, 2021)
- Employment Agreement by and between the Registrant and Russell Barton (Filed With SEC on June 9, 2021)
